BCR mutation is a key part of the pathogenesis of chronic myeloid leukemia, the BCR-ABL1 fusion (Philadelphia chromosome), where the upregulation of tyrosine kinase activity drives leukemic cell proliferation. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.